1 Min Read
Jan 10 (Reuters) - Ariad Pharmaceuticals Inc:
* If deal is terminated by co, to enter definitive agreement with respect to superior proposal, co to pay termination fee of $169 million Source text - bit.ly/2ido9QF Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.